Target intelligence / Profile preview

Neurotrophin (NT)

Target
NT
Molecular classification
Growth factor, Receptor ligand
01

Overview

Neurotrophins are a family of signaling proteins essential for the development, survival, and maintenance of neurons in the central and peripheral nervous systems [1]. The family primarily consists of Nerve Growth Factor (NGF), Brain-Derived Neurotrophic Factor (BDNF), Neurotrophin-3 (NT-3), and Neurotrophin-4 (NT-4) [2]. These proteins function by binding to two distinct classes of receptors: the high-affinity Tropomyosin receptor kinase (Trk) family (TrkA, TrkB, and TrkC) and the low-affinity p75 neurotrophin receptor (p75NTR) [5]. Dysregulation of neurotrophin signaling is linked to a wide range of conditions, including neurodegenerative diseases like Alzheimer's, psychiatric disorders such as depression, and chronic pain syndromes [4]. In oncology, chromosomal rearrangements leading to NTRK gene fusions result in constitutive activation of Trk signaling, driving various solid tumors [3]. Therapeutic interventions include monoclonal antibodies that target the ligands (e.g., Tanezumab for pain) and small-molecule inhibitors that target the receptor kinases (e.g., Larotrectinib for cancer) [3, 4].

Other names
Neurotrophic factorNeurotrophin familyNTF
02

Mechanism of action

Neurotrophin signaling is modulated through ligand sequestration by monoclonal antibodies (e.g., anti-NGF), inhibition of downstream receptor tyrosine kinases (Trk inhibitors), or activation of receptors via small molecule mimetics.

03

Biological functions

Neuronal survivalSynaptic plasticityAxonal growthCell differentiationApoptosis regulation
04

Disease associations

Neurodegenerative diseaseChronic painCancerDepressionPsychiatric disorders
05

Safety considerations

Rapidly progressive osteoarthritis (RPOA) with anti-NGF therapyDizziness and ataxia with Trk inhibitorsWeight gain and hyperphagiaParesthesiaCognitive impairment
06

Interacting drugs

Tanezumab

7 more in the full profile.

07

Biomarkers

NTRK1/2/3 gene fusionsBDNF serum/plasma levelsNGF levels in synovial fluidPro-NGF/NGF ratio

Beyond the preview

Go deeper on Neurotrophin (NT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurotrophin (NT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call